Paper Details

  1. Home
  2. Paper Details

Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.

Author: BarreraJ M, BrugueraM, CampistolJ M, CasellasJ, CostaJ, EsforzadoN, MartínezJ, ModolJ, OlivaJ A, PieraJ, PonsM, RosellóL, VecianaL, de Las CuevasX

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Interferon (IFN) therapy was found to be effective in treating chronic hepatitis C in haemodialysis (HD) patients. IFN therapy also had a beneficial effect on the course of liver disease following renal transplantation (RT).
Paper Details　
Original Abstract of the Article :
BACKGROUND: Hepatitis C virus (HCV) infection represents an important problem for the dialysis population due to its high prevalence and the long-term development of chronic liver disease, particularly following renal transplantation. METHODS: In order to assess the efficacy and tolerance of interf...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/ndt/14.11.2704

データ提供：米国国立医学図書館（NLM）

A Challenging Journey: Managing Hepatitis C in Hemodialysis Patients

Hepatitis C virus (HCV) infection, like a tenacious desert sandstorm, can pose significant challenges for individuals undergoing hemodialysis. This study delves into the effectiveness and safety of interferon-alpha(2b) in treating chronic HCV infection in this vulnerable population.

Researchers conducted a randomized, open-label study comparing interferon therapy to a control group in HCV-positive hemodialysis patients. They discovered that interferon therapy significantly reduced HCV RNA levels in a majority of patients, suggesting its potential as a treatment option. However, the study also highlighted the need for careful monitoring due to potential side effects and the possibility of virological relapse.

A New Path Through the Desert of HCV: Treating Patients on Dialysis

This study provides valuable insights into the management of HCV infection in hemodialysis patients. The findings suggest that interferon therapy can be effective in reducing HCV RNA levels, but further research is needed to optimize treatment strategies and minimize the risk of relapse.

Navigating the Desert of HCV Infection: Understanding Treatment Options and Risks

For individuals undergoing hemodialysis and facing HCV infection, it is crucial to discuss treatment options and potential risks with a healthcare professional. This study highlights the potential benefits of interferon therapy while emphasizing the need for careful monitoring and management.

Dr. Camel's Conclusion

This research, like a resourceful desert traveler seeking a solution to a challenging situation, explores the effectiveness of interferon therapy in treating HCV infection in hemodialysis patients. While interferon therapy can be effective, careful monitoring and management are crucial to mitigate potential side effects and ensure optimal outcomes.

Date :
  1. Date Completed 1999-11-30
  2. Date Revised 2019-05-13
Further Info :

Pubmed ID

10534516

DOI: Digital Object Identifier

10.1093/ndt/14.11.2704

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.